Rimonabant Redux?
New Drug Stays Out of Brain, Fights Metabolic Disorders
The typical headache for drug developers is a drug that won't cross the blood-brain barrier. But researchers from the National Institutes of Health and Jenrin Discovery Inc. hope to find success by preventing that crossing.